https://www.onhealthcare.tech/p/organ-procurement-under-federal-fireThoughts on Healthcare Markets & Technologyen2026-08-10T12:59:33+00:00Organ Procurement Under Federal Fire: How Cost-Plus Reimbursement, a 2020 Metric Rewrite, and the DCD Boom Turned Death Determination and Organ Allocation Into Healthcare’s Next Compliance Fighthttps://www.onhealthcare.tech/p/part-ii-organ-procurement-under-federalThoughts on Healthcare Markets & Technologyen2026-08-10T12:55:01+00:00Part II: Organ Procurement Under Federal Fire: How Cost-Plus Reimbursement, a 2020 Metric Rewrite and the DCD Boom Turned Death Determination & Organ Allocation Into Healthcare's Next Compliance Fighthttps://www.onhealthcare.tech/p/part-i-organ-procurement-under-federalThoughts on Healthcare Markets & Technologyen2026-08-10T12:53:49+00:00Part I: Organ Procurement Under Federal Fire: How Cost-Plus Reimbursement, a 2020 Metric Rewrite, and the DCD Boom Turned Death Determination & Organ Allocation Into Healthcare's Next Compliance Fighthttps://www.onhealthcare.tech/p/sinclair-says-age-reversal-is-already-741Thoughts on Healthcare Markets & Technologyen2026-08-09T19:50:50+00:00Sinclair Says Age Reversal Is Already In Humans: What Is Actually Being Dosed, Why The Endpoint Is Vision Instead Of Aging, And What The FDA Would Need To Approve An Actual Geroprotectorhttps://www.onhealthcare.tech/p/sinclair-says-age-reversal-is-alreadyThoughts on Healthcare Markets & Technologyen2026-08-09T19:42:23+00:00Sinclair Says Age Reversal Is Already In Humans: What Is Actually Being Dosed, Why The Endpoint Is Vision Instead Of Aging, And What The FDA Would Need To Approve An Actual Geroprotectorhttps://www.onhealthcare.tech/p/hrsas-revised-340b-rebate-pilot-explained-46cThoughts on Healthcare Markets & Technologyen2026-08-09T11:49:43+00:00HRSA’s Revised 340B Rebate Pilot Explained: What Claims-Based Rebates on 25 Negotiated Drugs Actually Change for Hospitals, Manufacturers, and TPAs, and Whether It Fixes 340B Transparencyhttps://www.onhealthcare.tech/p/hrsas-revised-340b-rebate-pilot-explainedThoughts on Healthcare Markets & Technologyen2026-08-09T11:42:55+00:00HRSA's Revised 340B Rebate Pilot Explained: What Claims-Based Rebates on 25 Negotiated Drugs Actually Change for Hospitals, Manufacturers, and TPAs, and Whether It Fixes 340B Transparency